This research proposal involves the manipulation of the mammalian genome as a means to probe gene function. The overall aim of this project is to mutate by gene targeting the transforming growth factor-beta-1 (TGF-beta 1) gene in the mouse germline in order to understand the role that TGF-beta 1 plays in the control of growth, differentiation, and homeostasis in the embryo. The vehicle for accomplishing this is the mouse embryonic stem (ES) cell. The TGF-beta 1 gene will be altered in ES cells in a pre- determined manner by targeted gene mutation, and the mutated cells will be used to reconstitute an entire mouse, and to produce complex embryoid structures in culture. The developmental processes of growth and differentiation affected by this mutation will delineate the multiple functions of TGF-beta 1 in the complex settings of the cultured embryonic structures and of the transgenic embryos. (1) The first specific aim is to mutate by targeted gene modification one of the autosomal TGF-beta 1 genes in ES cells. (2) The second specific aim is to use the genetically modified ES cells to generate by blastocyst injection a transgenic mouse heterozygous for a functional TGF-beta 1 gene. (3) The third specific aim is to generate homozygous state in which the TGF-beta 1 expression is totally lacking. When this is done by breeding heterozygous animals to the homozygous state, the possible effects of TGF- beta 1 deficiency on pre-implantation embryos can be studied. When the second copy of the gene is mutated by a second round of gene targeting in ES cells, the possible effects of TGF-beta 1 deficiency on post- implantation embryogenesis can be investigated both in ES cells differentiating in culture, and in chimeric embryos produced by blastocyst injection. The homozygous state will also be generated in mosaic patches by two different approaches (i) within normal embryos by blastocyst injection of just one or two TGF-beta 1-deficient ES cells into normal blastocysts, thereby producing weakly chimeric animals; and (ii) in the offspring of irradiated pregnant females heterozygous for the TGF-beta 1 gene.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD026471-04
Application #
3327960
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1990-05-01
Project End
1995-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Daniel, Scott G; Ball, Corbie L; Besselsen, David G et al. (2017) Functional Changes in the Gut Microbiome Contribute to Transforming Growth Factor ?-Deficient Colon Cancer. mSystems 2:
Doetschman, Thomas (2011) GI GEMs: genetically engineered mouse models of gastrointestinal disease. Gastroenterology 140:380-385.e2
House, Stacey L; House, Brian E; Glascock, Betty et al. (2010) Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase. Mol Cell Pharmacol 2:143-154
Liao, Siyun; Bodmer, Janet R; Azhar, Mohamad et al. (2010) The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury. J Mol Cell Cardiol 48:1245-54
Azhar, Mohamad; Runyan, Raymond B; Gard, Connie et al. (2009) Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Dev Dyn 238:431-42
Doetschman, Thomas (2009) Influence of genetic background on genetically engineered mouse phenotypes. Methods Mol Biol 530:423-33
Saxena, Vijay; Lienesch, Douglas W; Zhou, Min et al. (2008) Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J Immunol 180:1903-12
Bommireddy, Ramireddy; Babcock, George F; Singh, Ram R et al. (2008) TGFbeta1 deficiency does not affect the generation and maintenance of CD4+CD25+FOXP3+ putative Treg cells, but causes their numerical inadequacy and loss of regulatory function. Clin Immunol 127:206-13
Bommireddy, Ramireddy; Doetschman, Thomas (2007) TGFbeta1 and Treg cells: alliance for tolerance. Trends Mol Med 13:492-501
Bommireddy, Ramireddy; Pathak, Leena J; Martin, Jennifer et al. (2006) Self-antigen recognition by TGF beta1-deficient T cells causes their activation and systemic inflammation. Lab Invest 86:1008-19

Showing the most recent 10 out of 36 publications